Yeah the royalty story is huge. No mention of dividend and/or buyback. Hope they use their cash balance wisely.
LANI is going to become big news globally and could attract a sweet deal from a large pharma seeing the success of Relenza and Tamiflu. LANI is far superior... note that LANI like Relenza also works against the H1N1 seasonal strain resistant to tamiflu. Good news.
Hope they are testing it on the swine flu.
